Valeo Financial Advisors, LLC Glaukos Corp Transaction History

Valeo Financial Advisors, LLC

  • $3.97 Billion
  • Q4 2024

A detailed history of Valeo Financial Advisors, LLC transactions in Glaukos Corp stock. As of the latest transaction made, Valeo Financial Advisors, LLC holds 7,700 shares of GKOS stock, worth $744,359. This represents 0.03% of its overall portfolio holdings.

Number of Shares
7,700
Previous 7,877 2.25%
Holding current value
$744,359
Previous $1.03 Million 12.48%
% of portfolio
0.03%
Previous 0.03%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 30, 2025
SELL
$126.42 - $152.67 $22,376 - $27,022
-177 Reduced 2.25%
7,700 $1.15 Million
Q3 2024

Oct 10, 2024
BUY
$113.62 - $135.39 $79,534 - $94,772
700 Added 9.75%
7,877 $1.03 Million
Q2 2024

Jul 10, 2024
SELL
$89.48 - $118.35 $157,037 - $207,704
-1,755 Reduced 19.65%
7,177 $849,000
Q1 2024

Apr 19, 2024
BUY
$76.4 - $96.33 $11,460 - $14,449
150 Added 1.71%
8,932 $842,000
Q4 2023

Jan 29, 2024
SELL
$59.53 - $85.11 $17,859 - $25,533
-300 Reduced 3.3%
8,782 $698,000
Q3 2023

Oct 19, 2023
BUY
$69.23 - $79.09 $229,289 - $261,946
3,312 Added 57.4%
9,082 $683,000
Q4 2022

Feb 09, 2023
BUY
$40.82 - $57.75 $21,512 - $30,434
527 Added 10.05%
5,770 $252,000
Q2 2022

Aug 03, 2022
BUY
$34.86 - $63.77 $8,470 - $15,496
243 Added 4.86%
5,243 $238,000
Q3 2021

Nov 02, 2021
BUY
$47.43 - $84.23 $16,363 - $29,059
345 Added 7.41%
5,000 $241,000
Q1 2021

Apr 12, 2021
SELL
$70.43 - $97.42 $10,212 - $14,125
-145 Reduced 3.02%
4,655 $391,000
Q3 2020

Oct 28, 2020
BUY
$37.23 - $50.97 $4,318 - $5,912
116 Added 2.48%
4,800 $238,000
Q2 2020

Jul 20, 2020
BUY
$28.78 - $46.83 $719 - $1,170
25 Added 0.54%
4,684 $180,000
Q1 2020

Apr 13, 2020
BUY
$25.53 - $70.14 $56,855 - $156,201
2,227 Added 91.57%
4,659 $157,000
Q4 2019

Jan 24, 2020
BUY
$54.18 - $65.64 $10,944 - $13,259
202 Added 9.06%
2,432 $132,000
Q3 2019

Oct 15, 2019
BUY
$58.58 - $83.91 $527 - $755
9 Added 0.41%
2,230 $139,000
Q2 2019

Jul 10, 2019
SELL
$63.59 - $78.71 $45,784 - $56,671
-720 Reduced 24.48%
2,221 $167,000
Q1 2019

Apr 12, 2019
SELL
$50.75 - $80.54 $53,490 - $84,889
-1,054 Reduced 26.38%
2,941 $230,000
Q4 2018

Jan 30, 2019
SELL
$52.18 - $67.93 $14,610 - $19,020
-280 Reduced 6.55%
3,995 $224,000
Q3 2018

Nov 01, 2018
SELL
$38.13 - $68.37 $8,579 - $15,383
-225 Reduced 5.0%
4,275 $248,000
Q4 2017

Feb 09, 2018
BUY
$24.5 - $36.01 $28,175 - $41,411
1,150 Added 34.33%
4,500 $115,000
Q3 2017

Nov 14, 2017
BUY
$31.26 - $42.03 $104,721 - $140,800
3,350
3,350 $111,000

Others Institutions Holding GKOS

# of Institutions
355
Shares Held
50.1M
Call Options Held
282K
Put Options Held
401K
View Full List

About GLAUKOS Corp

GKOS Quotes by TradingView
  • Ticker GKOS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,596,900
  • Market Cap $4.6B
  • Description
  • Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...
More about GKOS
Track This Portfolio

Track Valeo Financial Advisors, LLC Portfolio

Follow Valeo Financial Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Valeo Financial Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email